Prevalence of antibodies to adenovirus serotypes 4 and 7 among unimmunized US Army trainees: Results of a retrospective nationwide seroprevalence survey

被引:55
作者
Ludwig, SL
Brundage, JF
Kelley, PW
Nang, R
Towle, C
Schnurr, DP
Crawford-Miksza, L
Gaydos, JC
机构
[1] Walter Reed Army Med Ctr, Walter Reed Army Inst Res, AMSA, USACHPPM, Washington, DC 20307 USA
[2] USA, Ctr Hlth Promot & Prevent Med, Aberdeen Proving Ground, MD USA
[3] Henry M Jackson Fdn, Rockville, MD USA
[4] Calif Dept Hlth Serv, Viral & Rickettsial Dis Lab, Berkeley, CA 94704 USA
关键词
D O I
10.1086/314498
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The 1996 production halt of adenovirus types 4 and 7 vaccines prompted concerns about the resurgence of large respiratory disease outbreaks among US military basic trainees. This serosurvey was conducted to assess the current susceptibility of the trainee population to these viruses. A stratified, random sample (n = 303) of trainees' sera was tested using a quantitative colorimetric microneutralization assay to demonstrate antibody titers considered to provide immunologic protection against each adenovirus type. Results were analyzed for relationships between susceptibility and 4 demographic factors-gender, race, prior military service, and age, Results showed that 66% and 73% of trainees were susceptible to serotypes 4 and 7, respectively. Nearly 90% were susceptible to at least one serotype, Susceptibility was significantly (P <.05) related to lack of prior military service and younger age. Consistent with a serosurvey conducted 20 years ago, these results demonstrated significant susceptibility to two vaccine-preventable causes of disease. These findings may have civilian implications.
引用
收藏
页码:1776 / 1778
页数:3
相关论文
共 15 条
[1]  
BARAZZA EM, 1995, ADENOVIRUS OUTBREAK, V1, P9
[2]  
Brundage JF, 1996, PEDIATRICS, V97, P964
[3]   IMMUNIZATION BY SELECTIVE INFECTION WITH TYPE 4 ADENOVIRUS GROWN IN HUMAN DIPLOID TISSUE CULTURE .I. SAFETY AND LACK OF ONCOGENICITY AND TESTS FOR POTENCY IN VOLUNTEERS [J].
CHANOCK, RM ;
LUDWIG, W ;
HEUBNER, RJ ;
CATE, TR ;
CHU, LW .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1966, 195 (06) :445-&
[4]   ADENOVIRUS VACCINES IN MILITARY RECRUIT POPULATIONS - COST-BENEFIT ANALYSIS [J].
COLLIS, PB ;
DUDDING, BA ;
WINTER, PE ;
RUSSELL, PK ;
BUESCHER, EL .
JOURNAL OF INFECTIOUS DISEASES, 1973, 128 (06) :745-752
[5]   QUANTITATIVE COLORIMETRIC MICRONEUTRALIZATION ASSAY FOR CHARACTERIZATION OF ADENOVIRUSES [J].
CRAWFORDMIKSZA, LK ;
SCHNURR, DP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (09) :2331-2334
[6]  
DINGLE JH, 1968, AM REV RESPIR DIS, V97, P1
[7]   ANALYSIS OF HOSPITALIZATIONS FOR ACUTE RESPIRATORY-DISEASE IN RECRUITS IMMUNIZED WITH ADENOVIRUS TYPE-4 AND TYPE-7 VACCINES [J].
DUDDING, BA ;
RUSSELL, PK ;
TOP, FH ;
SCOTT, RM ;
BUESCHER, EL .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1972, 95 (02) :140-&
[8]   ACUTE RESPIRATORY-DISEASE IN MILITARY TRAINEES - ADENOVIRUS SURVEILLANCE PROGRAM, 1966-1971 [J].
DUDDING, BA ;
TOP, FH ;
WINTER, PE ;
BUESCHER, EL ;
LAMSON, TH ;
LEIBOVITZ, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1973, 97 (03) :187-198
[9]   ADENOVIRUS VACCINES IN THE US MILITARY [J].
GAYDOS, CA ;
GAYDOS, JC .
MILITARY MEDICINE, 1995, 160 (06) :300-304
[10]  
HILLEMAN MR, 1954, P SOC EXP BIOL MED, V85, P183, DOI 10.3181/00379727-85-20825